IINN - CONSENSUS CO - Inspira Technologies Oxy

Inspira Technologies Oxy (IINN) is making a technological leap in resuscitation by creating blood oxygenation systems that do not require intubation. This price trend, valued at , complements data on the business's high scalability: patents allow for reduced device production costs while maintaining premium margins. The model relies on significant pricing power, as the unique ART devices are indispensable for hospitals.

For Inspira Technologies Oxy (IINN), the weighted consensus target price reflects the market's valuation of the business model's resilience, where the risk of dependence on CDMO vendors is mitigated by long-term contracts. This indicator represents the arithmetic mean of target prices from investment banks, aggregating the recalculation of stress scenarios and the asset's fundamental support, which allows investors to determine the margin of safety when analyzing liquidity.